Biphenyl

Biphenyl

SCHEMBL790630

c1ccc(-c2ccccc2)cc1.c1ccc(-c2ccccc2)cc1.c1cnnnc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
NOTUM Q6P988 2/20 0.55
ATM Q13315 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL790623 1.00 ALDH1A1 (0.56) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL418438 1.00 ALDH1A1 (0.56) ALDH1A1NOTUMATMRAB9ANPC1
SCHEMBL28449767 0.89 NISCH (0.47) ALDH1A1NOTUMNPC1GABRA1GABRG2
Biphenyl SCHEMBL4430627 0.87 MMP3 (0.56) ALDH1A1NOTUMRAB9ANPC1CYP3A4
SCHEMBL2920544 0.86 NISCH (0.45) ALDH1A1NOTUMMAPK1SMN1; SMN2HSD17B10
SCHEMBL16294953 0.86 NISCH (0.45) ALDH1A1NOTUMMAPK1SMN1; SMN2HSD17B10
Biphenyl SCHEMBL16469972 0.85 L3MBTL1 (0.52) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl-4-Amine SCHEMBL29066153 0.85 CYP3A4 (0.68) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL27478909 0.84 ALDH1A1 (0.60) ALDH1A1NOTUMATMRAB9ANPC1
Biphenyl SCHEMBL27722886 0.83 ALDH1A1 (0.82) ALDH1A1NOTUMATMRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106659653-B Sunscreen formulations optimized for vitamin D formation 巴斯夫欧洲公司 2022-04-05 CN disclosed
EP-2616041-B1 USE OF SPECIFIC BIS(BIPHENYL)TRIAZINE DERIVATIVES AND MIXTURES THEREOF AS UV ABSORBERS BASF SE (DE) 2018-08-22 EP disclosed
EP-2355791-B1 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO-GROUPS BASF SE (DE) 2016-09-28 EP disclosed
US-8986662-B2 Use of silane and siloxane bis(biphenyl) triazine derivatives as UV absorbers BASF SE (DE) 2015-03-24 US disclosed
US-8585782-B2 Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers BASF SE (DE) 2013-11-19 US disclosed
US-8529877-B2 Benzylidene compounds comprising phosphono-groups BASF SE (DE) 2013-09-10 US disclosed
EP-2629749-A1 USE OF SILANE AND SILOXANE BIS(BIPHENYL)TRIAZINE DERIVATIVES AS UV ABSORBERS BASF SE (DE) 2013-08-28 EP disclosed
US-20130202542-A1 USE OF SILANE AND SILOXANE BIS(BIPHENYL) TRIAZINE DERIVATIVES AS UV ABSORBERS BASF SE (DE) 2013-08-08 US disclosed
EP-2616041-A1 USE OF SPECIFIC BIS(BIPHENYL)TRIAZINE DERIVATIVES AND MIXTURES THEREOF AS UV ABSORBERS BASF SE (DE) 2013-07-24 EP disclosed
US-20130164231-A1 Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers BASF SE (DE) 2013-06-27 US disclosed
WO-2012052499-A1 USE OF SILANE AND SILOXANE BIS(BIPHENYL)TRIAZINE DERIVATIVES AS UV ABSORBERS BASF SE (DE) 2012-04-26 WO disclosed
WO-2012034932-A1 USE OF SPECIFIC BIS(BIPHENYL)TRIAZINE DERIVATIVES AND MIXTURES THEREOF AS UV ABSORBERS BASF SE (DE) 2012-03-22 WO disclosed
US-20110212039-A1 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO-GROUPS BASF SE (DE) 2011-09-01 US disclosed
EP-2355791-A2 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO-GROUPS BASF SE (DE) 2011-08-17 EP disclosed
WO-2010054966-A2 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO-GROUPS BASF SE (DE) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212039-A1 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO-GROUPS NR1H2, ESRRA, NR1H3 ALDH1A1 4360/4885NOTUM 3154/4885ATM 3321/4885
US-20130164231-A1 Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers NR1H2, CBR3, NR1H3 ALDH1A1 2155/4885NOTUM 2350/4885ATM 2986/4885
US-20130202542-A1 USE OF SILANE AND SILOXANE BIS(BIPHENYL) TRIAZINE DERIVATIVES AS UV ABSORBERS CCNL2, MSR1, CYP2S1 ALDH1A1 424/4885NOTUM 4043/4885ATM 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.